DERMAPHARM HOLDING SE (DMP.DE) Stock Price, Forecast & Analysis
FRA:DMP • DE000A2GS5D8
DMP.DE Key Statistics, Chart & Performance
The current stock price of DMP.DE is 37.675 EUR. In the past month the price increased by 12.96%. In the past year, price increased by 1.02%.
DMP.DE Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to DMP.DE. When comparing the yearly performance of all stocks, DMP.DE turns out to be only a medium performer in the overall market: it outperformed 40.94% of all stocks.
DMP.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE. DMP.DE has only an average score on both its financial health and profitability.
DMP.DE Financial Highlights
Over the last trailing twelve months DMP.DE reported a non-GAAP Earnings per Share(EPS) of 2.15. The EPS increased by 28.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10% | ||
| ROA | 5.48% | ||
| ROE | 17.87% | ||
| Debt/Equity | 1.44 |
DMP.DE Forecast & Estimates
11 analysts have analysed DMP.DE and the average price target is 43.25 EUR. This implies a price increase of 14.79% is expected in the next year compared to the current price of 37.675.
For the next year, analysts expect an EPS growth of 11.31% and a revenue growth -0.75% for DMP.DE
DMP.DE Ownership
DMP.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1SAN | SANOFI | 9.64 | 196.87B | ||
| SAN | SANOFI | 9.52 | 196.725B | ||
| SNW | SANOFI | 9.63 | 196.652B | ||
| MRK | MERCK KGAA | 14.25 | 54.891B | ||
| UCB | UCB SA | 24.35 | 48.55B | ||
| UNC | UCB SA | 24.22 | 48.452B | ||
| 1BAYN | BAYER AG-REG | 8.39 | 40.255B | ||
| BAYN | BAYER AG-REG | 8 | 39.896B | ||
| IPN | IPSEN | 14.07 | 13.778B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 16.26 | 9.896B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About DMP.DE
Company Profile
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company is headquartered in Gruenwald, Bayern and currently employs 3,610 full-time employees. The company went IPO on 2018-02-09. The firm operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. The company holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The firm offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. The company is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Company Info
DERMAPHARM HOLDING SE
Lil-Dagover-Ring 7
Gruenwald BAYERN DE
Employees: 3610
Phone: 4989641860
DERMAPHARM HOLDING SE / DMP.DE FAQ
What does DMP do?
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company is headquartered in Gruenwald, Bayern and currently employs 3,610 full-time employees. The company went IPO on 2018-02-09. The firm operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. The company holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The firm offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. The company is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Can you provide the latest stock price for DERMAPHARM HOLDING SE?
The current stock price of DMP.DE is 37.675 EUR. The price decreased by -4.98% in the last trading session.
Does DERMAPHARM HOLDING SE pay dividends?
DERMAPHARM HOLDING SE (DMP.DE) has a dividend yield of 2.29%. The yearly dividend amount is currently 0.88.
What is the ChartMill technical and fundamental rating of DMP stock?
DMP.DE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the analyst forecast for DMP.DE stock?
11 analysts have analysed DMP.DE and the average price target is 43.25 EUR. This implies a price increase of 14.79% is expected in the next year compared to the current price of 37.675.
What sector and industry does DERMAPHARM HOLDING SE belong to?
DERMAPHARM HOLDING SE (DMP.DE) operates in the Health Care sector and the Pharmaceuticals industry.